Clinical trial NCT03301077: Mental Health in Austrian Teenagers (MHAT)
Official title: The Mental Health in Austrian Teenagers (MHAT) - Study: First Epidemiological Survey
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Mental Disorders
Keywords: children and adolescents
mental health
epidemiology
psychiatric disorders
Lead sponsor: Medical University of Vienna
Sponsor class: OTHER
Collaborators: name: Ludwig Boltzmann Institute Health Promotion Research
name: Pharmig - Gesundheitsziele aus dem Rahmen-Pharmavertrag
First posted: 2017-10-04
Enrollment: 4000
Sex: ALL
Minimum age (years): 10
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Observational model: OTHER
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: general population

Brief summary: The purpose of the Mental Health in Austrian Teenagers (MHAT) - Study is to collect the first epidemiological data on mental health and psychiatric disorders in a representative sample of Austrian adolescents between 10 and 18 years.

Detailed description: Knowing about the prevalence of psychiatric disorders and related risk and protective factors is essential for the development of prevention programs and therapeutic approaches. Up to now, no epidemiological data on prevalence rates of psychiatric disorders and related risk and protective factors based on a representative sample is available for Austrian adolescents.

The aim of the study is to present rates of behavioral, emotional and social problems as well as prevalence rates of mental disorders. Furthermore the investigators want to examine risk factors, protective factors and quality of life in a large sample of adolescents aged 10 to 18 years. A two step design is chosen for this purpose to obtain diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5):

1. Phase 1 (screening) is a screening for emotional, behavioral and social problems as well as social and demographic correlates, risk and protective factors and quality of life.
2. Phase 2 (interviews) includes structured diagnostic interviews to assess psychiatric diagnoses according to DSM-5 criteria with adolescents above a predefined cut-off score in the screening, and a random sample of adolescents scoring below the cut-off.

Eligibility criteria: Inclusion Criteria:

* adolescents aged 10-18

Exclusion Criteria:

* no written informed consent possible due to intelligence or no willingness by parents to include minor

Primary outcomes:
measure: psychiatric problems (diagnoses based on the Diagnostic and Statistical Manual of the American Psychiatric Association, Version 5 (DSM-5)
timeFrame: 12 months
Secondary outcomes:
measure: rates of behavioral, emotional and social problems (representation of data collected at interview)
timeFrame: 12 months
measure: psychiatric disorder related risks and protective factors (representation of data collected at interviews)
timeFrame: 12 months
measure: quality of life (total score, self-perception, parent relation & home life, social support & peers, school environment and bullying)
timeFrame: 12 months
Other outcomes:
Locations:
city: Vienna
country: Austria
facility: Medical University of Vienna, Dep. of Child and Adolescent Psychiatry
Study officials:
affiliation: Medical University Vienna
name: Andreas Karwautz, MD, Prof
role: STUDY_DIRECTOR
affiliation: Ludwig Boltzmann Institute LBIHPR
name: Wolfgang Dür, Phd, Prof
role: STUDY_DIRECTOR
References: